RH

Rizwan Husain

Active Director Director DIN 11072682
DIN 11072682 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Rizwan Husain

Data last updated:

Rizwan Husain is a Director at Medjool Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11072682
Primary Designation Director
Industry Pharma
First Appointment 24 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medjool Lifesciences Private Limited U21000DL2025PTC447081
Director24 Apr 20252025Active

Board colleagues of Rizwan Husain

NameDINCompanyDesignation
Gulista11348570Medjool Lifesciences Private LimitedAdditional Director
Mohammad Asim11348430Medjool Lifesciences Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Medjool Lifesciences Private Limited
Premium access

Shareholding and investment profile for Rizwan Husain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rizwan Husain

Rizwan Husain currently holds 1 directorship: Medjool Lifesciences Private Limited (Director, since 24 Apr 2025).

Rizwan Husain was first appointed on 24 Apr 2025 as Director at Medjool Lifesciences Private Limited.

The current boards of Rizwan Husain's companies include Gulista (Medjool Lifesciences Private Limited), Mohammad Asim (Medjool Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available